Summary
The pharmaceutical industry, it is composed of companies developing and manufacturing innovative medicines and generic pharmaceuticals, as well as over–the-counter drug products. The sector is made up of a number of sub-sectors that service different market segments.
Health products are vitamins, minerals, herbal medicines, homeopathic preparations, probiotics and even some traditional medicines are also prescribed by doctor or any equivalent physician.
In this report, we mainly study the pharma and healthcare product.
According to APO Research, The global Pharma and Health Care market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The US & Canada market for Pharma and Health Care is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
Asia-Pacific market for Pharma and Health Care is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The China market for Pharma and Health Care is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
Europe market for Pharma and Health Care is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The major global companies of Pharma and Health Care include Johnson & Johnson, Novartis, Roche, AbbVie, Merck & Co., Bristol Myers Squibb, GlaxoSmithKline, Pfizer and Sanofi, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
Report Includes
This report presents an overview of global market for Pharma and Health Care, market size. Analyses of the global market trends, with historic market revenue data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Pharma and Health Care, also provides the revenue of main regions and countries. Of the upcoming market potential for Pharma and Health Care, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Pharma and Health Care revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global Pharma and Health Care market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2019 to 2030. Evaluation and forecast the market size for Pharma and Health Care revenue, projected growth trends, production technology, application and end-user industry.
Pharma and Health Care segment by Company
Johnson & Johnson
Novartis
Roche
AbbVie
Merck & Co.
Bristol Myers Squibb
GlaxoSmithKline
Pfizer
Sanofi
Takeda
AstraZeneca
Bayer
Eli Lilly & Co.
Gilead Sciences
Amgen
Novo Nordisk
Teva
Boehringer Ingelheim
Biogen
Astellas
Pharma and Health Care segment by Format
Bottle
Blister
Others
Pharma and Health Care segment by Prescription
OTC Drugs
Prescription Drugs
Pharma and Health Care segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Study Objectives
1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.
2. To present the key players, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Pharma and Health Care market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Pharma and Health Care and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Pharma and Health Care.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Revenue of Pharma and Health Care in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 4: Detailed analysis of Pharma and Health Care company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Pharma and Health Care revenue, gross margin, and recent development, etc.
Chapter 8: North America (US & Canada) by type, by application and by country, revenue for each segment.
Chapter 9: Europe by type, by application and by country, revenue for each segment.
Chapter 10: China type, by application, revenue for each segment.
Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.
Chapter 12: Middle East, Africa, and Latin America type, by application and by country, revenue for each segment.
Chapter 13: The main concluding insights of the report.
1 Market Overview
1.1 Product Definition
1.2 Pharma and Health Care Market by Format
1.2.1 Global Pharma and Health Care Market Size by Format, 2019 VS 2023 VS 2030
1.2.2 Bottle
1.2.3 Blister
1.2.4 Others
1.3 Pharma and Health Care Market by Prescription
1.3.1 Global Pharma and Health Care Market Size by Prescription, 2019 VS 2023 VS 2030
1.3.2 OTC Drugs
1.3.3 Prescription Drugs
1.4 Assumptions and Limitations
1.5 Study Goals and Objectives
2 Pharma and Health Care Market Dynamics
2.1 Pharma and Health Care Industry Trends
2.2 Pharma and Health Care Industry Drivers
2.3 Pharma and Health Care Industry Opportunities and Challenges
2.4 Pharma and Health Care Industry Restraints
3 Global Growth Perspective
3.1 Global Pharma and Health Care Market Perspective (2019-2030)
3.2 Global Pharma and Health Care Growth Trends by Region
3.2.1 Global Pharma and Health Care Market Size by Region: 2019 VS 2023 VS 2030
3.2.2 Global Pharma and Health Care Market Size by Region (2019-2024)
3.2.3 Global Pharma and Health Care Market Size by Region (2025-2030)
4 Competitive Landscape by Players
4.1 Global Pharma and Health Care Revenue by Players
4.1.1 Global Pharma and Health Care Revenue by Players (2019-2024)
4.1.2 Global Pharma and Health Care Revenue Market Share by Players (2019-2024)
4.1.3 Global Pharma and Health Care Players Revenue Share Top 10 and Top 5 in 2023
4.2 Global Pharma and Health Care Key Players Ranking, 2022 VS 2023 VS 2024
4.3 Global Pharma and Health Care Key Players Headquarters & Area Served
4.4 Global Pharma and Health Care Players, Product Type & Application
4.5 Global Pharma and Health Care Players Commercialization Time
4.6 Market Competitive Analysis
4.6.1 Global Pharma and Health Care Market CR5 and HHI
4.6.2 Global Top 5 and 10 Pharma and Health Care Players Market Share by Revenue in 2023
4.6.3 2023 Pharma and Health Care Tier 1, Tier 2, and Tier 3
5 Pharma and Health Care Market Size by Type
5.1 Global Pharma and Health Care Revenue by Type (2019 VS 2023 VS 2030)
5.2 Global Pharma and Health Care Revenue by Type (2019-2030)
5.3 Global Pharma and Health Care Revenue Market Share by Type (2019-2030)
6 Pharma and Health Care Market Size by Application
6.1 Global Pharma and Health Care Revenue by Application (2019 VS 2023 VS 2030)
6.2 Global Pharma and Health Care Revenue by Application (2019-2030)
6.3 Global Pharma and Health Care Revenue Market Share by Application (2019-2030)
7 Company Profiles
7.1 Johnson & Johnson
7.1.1 Johnson & Johnson Comapny Information
7.1.2 Johnson & Johnson Business Overview
7.1.3 Johnson & Johnson Pharma and Health Care Revenue and Gross Margin (2019-2024)
7.1.4 Johnson & Johnson Pharma and Health Care Product Portfolio
7.1.5 Johnson & Johnson Recent Developments
7.2 Novartis
7.2.1 Novartis Comapny Information
7.2.2 Novartis Business Overview
7.2.3 Novartis Pharma and Health Care Revenue and Gross Margin (2019-2024)
7.2.4 Novartis Pharma and Health Care Product Portfolio
7.2.5 Novartis Recent Developments
7.3 Roche
7.3.1 Roche Comapny Information
7.3.2 Roche Business Overview
7.3.3 Roche Pharma and Health Care Revenue and Gross Margin (2019-2024)
7.3.4 Roche Pharma and Health Care Product Portfolio
7.3.5 Roche Recent Developments
7.4 AbbVie
7.4.1 AbbVie Comapny Information
7.4.2 AbbVie Business Overview
7.4.3 AbbVie Pharma and Health Care Revenue and Gross Margin (2019-2024)
7.4.4 AbbVie Pharma and Health Care Product Portfolio
7.4.5 AbbVie Recent Developments
7.5 Merck & Co.
7.5.1 Merck & Co. Comapny Information
7.5.2 Merck & Co. Business Overview
7.5.3 Merck & Co. Pharma and Health Care Revenue and Gross Margin (2019-2024)
7.5.4 Merck & Co. Pharma and Health Care Product Portfolio
7.5.5 Merck & Co. Recent Developments
7.6 Bristol Myers Squibb
7.6.1 Bristol Myers Squibb Comapny Information
7.6.2 Bristol Myers Squibb Business Overview
7.6.3 Bristol Myers Squibb Pharma and Health Care Revenue and Gross Margin (2019-2024)
7.6.4 Bristol Myers Squibb Pharma and Health Care Product Portfolio
7.6.5 Bristol Myers Squibb Recent Developments
7.7 GlaxoSmithKline
7.7.1 GlaxoSmithKline Comapny Information
7.7.2 GlaxoSmithKline Business Overview
7.7.3 GlaxoSmithKline Pharma and Health Care Revenue and Gross Margin (2019-2024)
7.7.4 GlaxoSmithKline Pharma and Health Care Product Portfolio
7.7.5 GlaxoSmithKline Recent Developments
7.8 Pfizer
7.8.1 Pfizer Comapny Information
7.8.2 Pfizer Business Overview
7.8.3 Pfizer Pharma and Health Care Revenue and Gross Margin (2019-2024)
7.8.4 Pfizer Pharma and Health Care Product Portfolio
7.8.5 Pfizer Recent Developments
7.9 Sanofi
7.9.1 Sanofi Comapny Information
7.9.2 Sanofi Business Overview
7.9.3 Sanofi Pharma and Health Care Revenue and Gross Margin (2019-2024)
7.9.4 Sanofi Pharma and Health Care Product Portfolio
7.9.5 Sanofi Recent Developments
7.10 Takeda
7.10.1 Takeda Comapny Information
7.10.2 Takeda Business Overview
7.10.3 Takeda Pharma and Health Care Revenue and Gross Margin (2019-2024)
7.10.4 Takeda Pharma and Health Care Product Portfolio
7.10.5 Takeda Recent Developments
7.11 AstraZeneca
7.11.1 AstraZeneca Comapny Information
7.11.2 AstraZeneca Business Overview
7.11.3 AstraZeneca Pharma and Health Care Revenue and Gross Margin (2019-2024)
7.11.4 AstraZeneca Pharma and Health Care Product Portfolio
7.11.5 AstraZeneca Recent Developments
7.12 Bayer
7.12.1 Bayer Comapny Information
7.12.2 Bayer Business Overview
7.12.3 Bayer Pharma and Health Care Revenue and Gross Margin (2019-2024)
7.12.4 Bayer Pharma and Health Care Product Portfolio
7.12.5 Bayer Recent Developments
7.13 Eli Lilly & Co.
7.13.1 Eli Lilly & Co. Comapny Information
7.13.2 Eli Lilly & Co. Business Overview
7.13.3 Eli Lilly & Co. Pharma and Health Care Revenue and Gross Margin (2019-2024)
7.13.4 Eli Lilly & Co. Pharma and Health Care Product Portfolio
7.13.5 Eli Lilly & Co. Recent Developments
7.14 Gilead Sciences
7.14.1 Gilead Sciences Comapny Information
7.14.2 Gilead Sciences Business Overview
7.14.3 Gilead Sciences Pharma and Health Care Revenue and Gross Margin (2019-2024)
7.14.4 Gilead Sciences Pharma and Health Care Product Portfolio
7.14.5 Gilead Sciences Recent Developments
7.15 Amgen
7.15.1 Amgen Comapny Information
7.15.2 Amgen Business Overview
7.15.3 Amgen Pharma and Health Care Revenue and Gross Margin (2019-2024)
7.15.4 Amgen Pharma and Health Care Product Portfolio
7.15.5 Amgen Recent Developments
7.16 Novo Nordisk
7.16.1 Novo Nordisk Comapny Information
7.16.2 Novo Nordisk Business Overview
7.16.3 Novo Nordisk Pharma and Health Care Revenue and Gross Margin (2019-2024)
7.16.4 Novo Nordisk Pharma and Health Care Product Portfolio
7.16.5 Novo Nordisk Recent Developments
7.17 Teva
7.17.1 Teva Comapny Information
7.17.2 Teva Business Overview
7.17.3 Teva Pharma and Health Care Revenue and Gross Margin (2019-2024)
7.17.4 Teva Pharma and Health Care Product Portfolio
7.17.5 Teva Recent Developments
7.18 Boehringer Ingelheim
7.18.1 Boehringer Ingelheim Comapny Information
7.18.2 Boehringer Ingelheim Business Overview
7.18.3 Boehringer Ingelheim Pharma and Health Care Revenue and Gross Margin (2019-2024)
7.18.4 Boehringer Ingelheim Pharma and Health Care Product Portfolio
7.18.5 Boehringer Ingelheim Recent Developments
7.19 Biogen
7.19.1 Biogen Comapny Information
7.19.2 Biogen Business Overview
7.19.3 Biogen Pharma and Health Care Revenue and Gross Margin (2019-2024)
7.19.4 Biogen Pharma and Health Care Product Portfolio
7.19.5 Biogen Recent Developments
7.20 Astellas
7.20.1 Astellas Comapny Information
7.20.2 Astellas Business Overview
7.20.3 Astellas Pharma and Health Care Revenue and Gross Margin (2019-2024)
7.20.4 Astellas Pharma and Health Care Product Portfolio
7.20.5 Astellas Recent Developments
8 North America
8.1 North America Pharma and Health Care Revenue (2019-2030)
8.2 North America Pharma and Health Care Revenue by Format (2019-2030)
8.2.1 North America Pharma and Health Care Revenue by Format (2019-2024)
8.2.2 North America Pharma and Health Care Revenue by Format (2025-2030)
8.3 North America Pharma and Health Care Revenue Share by Format (2019-2030)
8.4 North America Pharma and Health Care Revenue by Prescription (2019-2030)
8.4.1 North America Pharma and Health Care Revenue by Prescription (2019-2024)
8.4.2 North America Pharma and Health Care Revenue by Prescription (2025-2030)
8.5 North America Pharma and Health Care Revenue Share by Prescription (2019-2030)
8.6 North America Pharma and Health Care Revenue by Country
8.6.1 North America Pharma and Health Care Revenue by Country (2019 VS 2023 VS 2030)
8.6.2 North America Pharma and Health Care Revenue by Country (2019-2024)
8.6.3 North America Pharma and Health Care Revenue by Country (2025-2030)
8.6.4 United States
8.6.5 Canada
9 Europe
9.1 Europe Pharma and Health Care Revenue (2019-2030)
9.2 Europe Pharma and Health Care Revenue by Format (2019-2030)
9.2.1 Europe Pharma and Health Care Revenue by Format (2019-2024)
9.2.2 Europe Pharma and Health Care Revenue by Format (2025-2030)
9.3 Europe Pharma and Health Care Revenue Share by Format (2019-2030)
9.4 Europe Pharma and Health Care Revenue by Prescription (2019-2030)
9.4.1 Europe Pharma and Health Care Revenue by Prescription (2019-2024)
9.4.2 Europe Pharma and Health Care Revenue by Prescription (2025-2030)
9.5 Europe Pharma and Health Care Revenue Share by Prescription (2019-2030)
9.6 Europe Pharma and Health Care Revenue by Country
9.6.1 Europe Pharma and Health Care Revenue by Country (2019 VS 2023 VS 2030)
9.6.2 Europe Pharma and Health Care Revenue by Country (2019-2024)
9.6.3 Europe Pharma and Health Care Revenue by Country (2025-2030)
9.6.4 Germany
9.6.5 France
9.6.6 U.K.
9.6.7 Italy
9.6.8 Russia
10 China
10.1 China Pharma and Health Care Revenue (2019-2030)
10.2 China Pharma and Health Care Revenue by Format (2019-2030)
10.2.1 China Pharma and Health Care Revenue by Format (2019-2024)
10.2.2 China Pharma and Health Care Revenue by Format (2025-2030)
10.3 China Pharma and Health Care Revenue Share by Format (2019-2030)
10.4 China Pharma and Health Care Revenue by Prescription (2019-2030)
10.4.1 China Pharma and Health Care Revenue by Prescription (2019-2024)
10.4.2 China Pharma and Health Care Revenue by Prescription (2025-2030)
10.5 China Pharma and Health Care Revenue Share by Prescription (2019-2030)
11 Asia (Excluding China)
11.1 Asia Pharma and Health Care Revenue (2019-2030)
11.2 Asia Pharma and Health Care Revenue by Format (2019-2030)
11.2.1 Asia Pharma and Health Care Revenue by Format (2019-2024)
11.2.2 Asia Pharma and Health Care Revenue by Format (2025-2030)
11.3 Asia Pharma and Health Care Revenue Share by Format (2019-2030)
11.4 Asia Pharma and Health Care Revenue by Prescription (2019-2030)
11.4.1 Asia Pharma and Health Care Revenue by Prescription (2019-2024)
11.4.2 Asia Pharma and Health Care Revenue by Prescription (2025-2030)
11.5 Asia Pharma and Health Care Revenue Share by Prescription (2019-2030)
11.6 Asia Pharma and Health Care Revenue by Country
11.6.1 Asia Pharma and Health Care Revenue by Country (2019 VS 2023 VS 2030)
11.6.2 Asia Pharma and Health Care Revenue by Country (2019-2024)
11.6.3 Asia Pharma and Health Care Revenue by Country (2025-2030)
11.6.4 Japan
11.6.5 South Korea
11.6.6 India
11.6.7 Australia
11.6.8 China Taiwan
11.6.9 Southeast Asia
12 Middle East, Africa, Latin America
12.1 MEALA Pharma and Health Care Revenue (2019-2030)
12.2 MEALA Pharma and Health Care Revenue by Format (2019-2030)
12.2.1 MEALA Pharma and Health Care Revenue by Format (2019-2024)
12.2.2 MEALA Pharma and Health Care Revenue by Format (2025-2030)
12.3 MEALA Pharma and Health Care Revenue Share by Format (2019-2030)
12.4 MEALA Pharma and Health Care Revenue by Prescription (2019-2030)
12.4.1 MEALA Pharma and Health Care Revenue by Prescription (2019-2024)
12.4.2 MEALA Pharma and Health Care Revenue by Prescription (2025-2030)
12.5 MEALA Pharma and Health Care Revenue Share by Prescription (2019-2030)
12.6 MEALA Pharma and Health Care Revenue by Country
12.6.1 MEALA Pharma and Health Care Revenue by Country (2019 VS 2023 VS 2030)
12.6.2 MEALA Pharma and Health Care Revenue by Country (2019-2024)
12.6.3 MEALA Pharma and Health Care Revenue by Country (2025-2030)
12.6.4 Mexico
12.6.5 Brazil
12.6.6 Israel
12.6.7 Argentina
12.6.8 Colombia
12.6.9 Turkey
12.6.10 Saudi Arabia
12.6.11 UAE
13 Concluding Insights
14 Appendix
14.1 Reasons for Doing This Study
14.2 Research Methodology
14.3 Research Process
14.4 Authors List of This Report
14.5 Data Source
14.5.1 Secondary Sources
14.5.2 Primary Sources
14.6 Disclaimer
List of Tables
Table 1. Global Pharma and Health Care Market Size Growth Rate by Format (US$ Million), 2019 VS 2023 VS 2030
Table 1. Bottle Major Manufacturers
Table 2. Blister Major Manufacturers
Table 3. Others Major Manufacturers
Table 4. Global Pharma and Health Care Market Size Growth Rate by Prescription (US$ Million), 2019 VS 2023 VS 2030
Table 5. OTC Drugs Major Manufacturers
Table 6. Prescription Drugs Major Manufacturers
Table 7. Pharma and Health Care Industry Trends
Table 8. Pharma and Health Care Industry Drivers
Table 9. Pharma and Health Care Industry Opportunities and Challenges
Table 10. Pharma and Health Care Industry Restraints
Table 11. Global Pharma and Health Care Market Size Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030
Table 12. Global Pharma and Health Care Market Size by Region (2019-2024) & (US$ Million)
Table 13. Global Pharma and Health Care Market Share by Region (2019-2024)
Table 14. Global Pharma and Health Care Market Size by Region (2025-2030) & (US$ Million)
Table 15. Global Pharma and Health Care Market Share by Region (2025-2030)
Table 16. Global Pharma and Health Care Revenue by Players (US$ Million) & (2019-2024)
Table 17. Global Pharma and Health Care Revenue Market Share by Players (2019-2024)
Table 18. Global Pharma and Health Care Key Players Ranking, 2022 VS 2023 VS 2024
Table 19. Global Pharma and Health Care Key Players Headquarters & Area Served
Table 20. Global Pharma and Health Care Players, Product Type & Application
Table 21. Global Pharma and Health Care Players Commercialization Time
Table 22. Global Players Market Concentration Ratio (CR5 and HHI)
Table 23. Global Pharma and Health Care by Players Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2023)
Table 24. Global Pharma and Health Care Revenue by Format 2019 VS 2023 VS 2030 (US$ Million)
Table 25. Global Pharma and Health Care Revenue by Format (2019-2024) & (US$ Million)
Table 26. Global Pharma and Health Care Revenue by Format (2025-2030) & (US$ Million)
Table 27. Global Pharma and Health Care Revenue Market Share by Format (2019-2024) & (US$ Million)
Table 28. Global Pharma and Health Care Revenue Market Share by Format (2025-2030) & (US$ Million)
Table 29. Global Pharma and Health Care Revenue by Prescription 2019 VS 2023 VS 2030 (US$ Million)
Table 30. Global Pharma and Health Care Revenue by Prescription (2019-2024) & (US$ Million)
Table 31. Global Pharma and Health Care Revenue by Prescription (2025-2030) & (US$ Million)
Table 32. Global Pharma and Health Care Revenue Market Share by Prescription (2019-2024) & (US$ Million)
Table 33. Global Pharma and Health Care Revenue Market Share by Prescription (2025-2030) & (US$ Million)
Table 34. Johnson & Johnson Company Information
Table 35. Johnson & Johnson Business Overview
Table 36. Johnson & Johnson Pharma and Health Care Revenue and Gross Margin (US$ Million) & (2019-2024)
Table 37. Johnson & Johnson Pharma and Health Care Product Portfolio
Table 38. Johnson & Johnson Recent Development
Table 39. Novartis Company Information
Table 40. Novartis Business Overview
Table 41. Novartis Pharma and Health Care Revenue and Gross Margin (US$ Million) & (2019-2024)
Table 42. Novartis Pharma and Health Care Product Portfolio
Table 43. Novartis Recent Development
Table 44. Roche Company Information
Table 45. Roche Business Overview
Table 46. Roche Pharma and Health Care Revenue and Gross Margin (US$ Million) & (2019-2024)
Table 47. Roche Pharma and Health Care Product Portfolio
Table 48. Roche Recent Development
Table 49. AbbVie Company Information
Table 50. AbbVie Business Overview
Table 51. AbbVie Pharma and Health Care Revenue and Gross Margin (US$ Million) & (2019-2024)
Table 52. AbbVie Pharma and Health Care Product Portfolio
Table 53. AbbVie Recent Development
Table 54. Merck & Co. Company Information
Table 55. Merck & Co. Business Overview
Table 56. Merck & Co. Pharma and Health Care Revenue and Gross Margin (US$ Million) & (2019-2024)
Table 57. Merck & Co. Pharma and Health Care Product Portfolio
Table 58. Merck & Co. Recent Development
Table 59. Bristol Myers Squibb Company Information
Table 60. Bristol Myers Squibb Business Overview
Table 61. Bristol Myers Squibb Pharma and Health Care Revenue and Gross Margin (US$ Million) & (2019-2024)
Table 62. Bristol Myers Squibb Pharma and Health Care Product Portfolio
Table 63. Bristol Myers Squibb Recent Development
Table 64. GlaxoSmithKline Company Information
Table 65. GlaxoSmithKline Business Overview
Table 66. GlaxoSmithKline Pharma and Health Care Revenue and Gross Margin (US$ Million) & (2019-2024)
Table 67. GlaxoSmithKline Pharma and Health Care Product Portfolio
Table 68. GlaxoSmithKline Recent Development
Table 69. Pfizer Company Information
Table 70. Pfizer Business Overview
Table 71. Pfizer Pharma and Health Care Revenue and Gross Margin (US$ Million) & (2019-2024)
Table 72. Pfizer Pharma and Health Care Product Portfolio
Table 73. Pfizer Recent Development
Table 74. Sanofi Company Information
Table 75. Sanofi Business Overview
Table 76. Sanofi Pharma and Health Care Revenue and Gross Margin (US$ Million) & (2019-2024)
Table 77. Sanofi Pharma and Health Care Product Portfolio
Table 78. Sanofi Recent Development
Table 79. Takeda Company Information
Table 80. Takeda Business Overview
Table 81. Takeda Pharma and Health Care Revenue and Gross Margin (US$ Million) & (2019-2024)
Table 82. Takeda Pharma and Health Care Product Portfolio
Table 83. Takeda Recent Development
Table 84. AstraZeneca Company Information
Table 85. AstraZeneca Business Overview
Table 86. AstraZeneca Pharma and Health Care Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 87. AstraZeneca Pharma and Health Care Product Portfolio
Table 88. AstraZeneca Recent Development
Table 89. Bayer Company Information
Table 90. Bayer Business Overview
Table 91. Bayer Pharma and Health Care Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 92. Bayer Pharma and Health Care Product Portfolio
Table 93. Bayer Recent Development
Table 94. Eli Lilly & Co. Company Information
Table 95. Eli Lilly & Co. Business Overview
Table 96. Eli Lilly & Co. Pharma and Health Care Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 97. Eli Lilly & Co. Pharma and Health Care Product Portfolio
Table 98. Eli Lilly & Co. Recent Development
Table 99. Gilead Sciences Company Information
Table 100. Gilead Sciences Business Overview
Table 101. Gilead Sciences Pharma and Health Care Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 102. Gilead Sciences Pharma and Health Care Product Portfolio
Table 103. Gilead Sciences Recent Development
Table 104. Amgen Company Information
Table 105. Amgen Business Overview
Table 106. Amgen Pharma and Health Care Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 107. Amgen Pharma and Health Care Product Portfolio
Table 108. Amgen Recent Development
Table 109. Novo Nordisk Company Information
Table 110. Novo Nordisk Business Overview
Table 111. Novo Nordisk Pharma and Health Care Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 112. Novo Nordisk Pharma and Health Care Product Portfolio
Table 113. Novo Nordisk Recent Development
Table 114. Teva Company Information
Table 115. Teva Business Overview
Table 116. Teva Pharma and Health Care Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 117. Teva Pharma and Health Care Product Portfolio
Table 118. Teva Recent Development
Table 119. Boehringer Ingelheim Company Information
Table 120. Boehringer Ingelheim Business Overview
Table 121. Boehringer Ingelheim Pharma and Health Care Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 122. Boehringer Ingelheim Pharma and Health Care Product Portfolio
Table 123. Boehringer Ingelheim Recent Development
Table 124. Biogen Company Information
Table 125. Biogen Business Overview
Table 126. Biogen Pharma and Health Care Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 127. Biogen Pharma and Health Care Product Portfolio
Table 128. Biogen Recent Development
Table 129. Astellas Company Information
Table 130. Astellas Business Overview
Table 131. Astellas Pharma and Health Care Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 132. Astellas Pharma and Health Care Product Portfolio
Table 133. Astellas Recent Development
Table 134. North America Pharma and Health Care Revenue by Format (2019-2024) & (US$ Million)
Table 135. North America Pharma and Health Care Revenue by Prescription (2019-2024) & (US$ Million)
Table 136. North America Pharma and Health Care Revenue by Country (2019 VS 2023 VS 2030) & (US$ Million)
Table 137. North America Pharma and Health Care Revenue by Country (2019-2024) & (US$ Million)
Table 138. North America Pharma and Health Care Revenue by Country (2025-2030) & (US$ Million)
Table 139. Europe Pharma and Health Care Revenue by Format (2019-2024) & (US$ Million)
Table 140. Europe Pharma and Health Care Revenue by Prescription (2019-2024) & (US$ Million)
Table 141. Europe Pharma and Health Care Revenue by Country (2019 VS 2023 VS 2030) & (US$ Million)
Table 142. Europe Pharma and Health Care Revenue by Country (2019-2024) & (US$ Million)
Table 143. Europe Pharma and Health Care Revenue by Country (2025-2030) & (US$ Million)
Table 144. China Pharma and Health Care Revenue by Format (2019-2024) & (US$ Million)
Table 145. China Pharma and Health Care Revenue by Prescription (2019-2024) & (US$ Million)
Table 146. Asia Pharma and Health Care Revenue by Format (2019-2024) & (US$ Million)
Table 147. Asia Pharma and Health Care Revenue by Prescription (2019-2024) & (US$ Million)
Table 148. Asia Pharma and Health Care Revenue by Country (2019 VS 2023 VS 2030) & (US$ Million)
Table 149. Asia Pharma and Health Care Revenue by Country (2019-2024) & (US$ Million)
Table 150. Asia Pharma and Health Care Revenue by Country (2025-2030) & (US$ Million)
Table 151. MEALA Pharma and Health Care Revenue by Format (2019-2024) & (US$ Million)
Table 152. MEALA Pharma and Health Care Revenue by Prescription (2019-2024) & (US$ Million)
Table 153. MEALA Pharma and Health Care Revenue by Country (2019 VS 2023 VS 2030) & (US$ Million)
Table 154. MEALA Pharma and Health Care Revenue by Country (2019-2024) & (US$ Million)
Table 155. MEALA Pharma and Health Care Revenue by Country (2025-2030) & (US$ Million)
Table 156. Research Programs/Design for This Report
Table 157. Authors List of This Report
Table 158. Secondary Sources
Table 159. Primary Sources
List of Figures
Figure 1. Pharma and Health Care Product Picture
Figure 2. Global Pharma and Health Care Market Size Growth Rate by Format (US$ Million), 2019 VS 2023 VS 2030
Figure 3. Global Pharma and Health Care Market Size Share 2019 VS 2023 VS 2030
Figure 4. Bottle Picture
Figure 5. Blister Picture
Figure 6. Others Picture
Figure 7. Global Pharma and Health Care Market Size Growth Rate by Prescription (US$ Million), 2019 VS 2023 VS 2030
Figure 8. Global Pharma and Health Care Market Size Share 2019 VS 2023 VS 2030
Figure 9. OTC Drugs Picture
Figure 10. Prescription Drugs Picture
Figure 11. Global Pharma and Health Care Market Size (US$ Million) & (2019-2030)
Figure 12. Global Pharma and Health Care Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 13. Global Pharma and Health Care Market Share by Region: 2019 VS 2023 VS 2030
Figure 14. Global Pharma and Health Care Players Revenue Share Top 10 and Top 5 in 2023
Figure 15. Players Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 16. Global Pharma and Health Care Revenue by Format (2019 VS 2023 VS 2030) & (US$ Million)
Figure 17. Global Pharma and Health Care Revenue Market Share 2019 VS 2023 VS 2030
Figure 18. Global Pharma and Health Care Revenue Market Share by Format (2019-2030)
Figure 19. Global Pharma and Health Care Revenue by Prescription (2019 VS 2023 VS 2030) & (US$ Million)
Figure 20. Global Pharma and Health Care Revenue Market Share by Prescription (2019 VS 2023 VS 2030)
Figure 21. Global Pharma and Health Care Revenue Market Share by Prescription (2019-2030)
Figure 22. North America Pharma and Health Care Revenue YoY Growth (2019-2030) & (US$ Million)
Figure 23. North America Pharma and Health Care Revenue by Type (2025-2030) & (US$ Million)
Figure 24. North America Pharma and Health Care Revenue Share by Type (2019-2030)
Figure 25. North America Pharma and Health Care Revenue by Application (2025-2030) & (US$ Million)
Figure 26. North America Pharma and Health Care Revenue Share by Application (2019-2030)
Figure 27. North America Pharma and Health Care Revenue Share by Country (2019-2030)
Figure 28. United States Pharma and Health Care Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 29. Canada Pharma and Health Care Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 30. Europe Pharma and Health Care Revenue YoY Growth (2019-2030) & (US$ Million)
Figure 31. Europe Pharma and Health Care Revenue by Type (2025-2030) & (US$ Million)
Figure 32. Europe Pharma and Health Care Revenue Share by Type (2019-2030)
Figure 33. Europe Pharma and Health Care Revenue by Application (2025-2030) & (US$ Million)
Figure 34. Europe Pharma and Health Care Revenue Share by Application (2019-2030)
Figure 35. Europe Pharma and Health Care Revenue Share by Country (2019-2030)
Figure 36. Germany Pharma and Health Care Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 37. France Pharma and Health Care Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 38. U.K. Pharma and Health Care Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 39. Italy Pharma and Health Care Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 40. Russia Pharma and Health Care Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 41. Nordic Countries Pharma and Health Care Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 42. China Pharma and Health Care Revenue YoY Growth (2019-2030) & (US$ Million)
Figure 43. China Pharma and Health Care Revenue by Type (2025-2030) & (US$ Million)
Figure 44. China Pharma and Health Care Revenue Share by Type (2019-2030)
Figure 45. China Pharma and Health Care Revenue by Application (2025-2030) & (US$ Million)
Figure 46. China Pharma and Health Care Revenue Share by Application (2019-2030)
Figure 47. Asia Pharma and Health Care Revenue YoY Growth (2019-2030) & (US$ Million)
Figure 48. Asia Pharma and Health Care Revenue by Type (2025-2030) & (US$ Million)
Figure 49. Asia Pharma and Health Care Revenue Share by Type (2019-2030)
Figure 50. Asia Pharma and Health Care Revenue by Application (2025-2030) & (US$ Million)
Figure 51. Asia Pharma and Health Care Revenue Share by Application (2019-2030)
Figure 52. Asia Pharma and Health Care Revenue Share by Country (2019-2030)
Figure 53. Japan Pharma and Health Care Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 54. South Korea Pharma and Health Care Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 55. India Pharma and Health Care Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 56. Australia Pharma and Health Care Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 57. China Taiwan Pharma and Health Care Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 58. Southeast Asia Pharma and Health Care Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 59. MEALA Pharma and Health Care Revenue YoY Growth (2019-2030) & (US$ Million)
Figure 60. MEALA Pharma and Health Care Revenue by Type (2025-2030) & (US$ Million)
Figure 61. MEALA Pharma and Health Care Revenue Share by Type (2019-2030)
Figure 62. MEALA Pharma and Health Care Revenue by Application (2025-2030) & (US$ Million)
Figure 63. MEALA Pharma and Health Care Revenue Share by Application (2019-2030)
Figure 64. MEALA Pharma and Health Care Revenue Share by Country (2019-2030)
Figure 65. Mexico Pharma and Health Care Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 66. South Korea Pharma and Health Care Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 67. Brazil Pharma and Health Care Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 68. Israel Pharma and Health Care Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 69. Argentina Pharma and Health Care Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 70. Colombia Pharma and Health Care Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 71. Turkey Pharma and Health Care Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 72. Saudi Arabia Pharma and Health Care Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 73. UAE Pharma and Health Care Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 74. Years Considered
Figure 75. Research Process
Figure 76. Key Executives Interviewed
